EP4054584
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
4.11.2020:
9.7.2025:
20884269.0
:
3.11.2040:
8.11.2025
:
METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR
4.11.2020
9.7.2025
8.11.2025
:
Resverlogix Corp.:
300, 4820 Richard Road SW, Calgary, AB T3E 6L1, CA
:
LEBIODA, Kenneth Eugene:
Calgary, AB T3Z 3T2, CA
:
HALLIDAY, Christopher Ross Armstrong:
Calgary, AB T2G 5P9, CA
:
KHAN, Aziz Naeem:
Calgary, AB T3E 7M7, CA
:
201962930860 P:
5.11.2019:
US
:
IB2020000912:
4.11.2020
:
A61K 31/517, A61P 9/00, C07D 239/91, A61K 31/70, A61K 31/7042, A61K 31/7048, A61K 45/06